CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 375 filers reported holding CRISPR THERAPEUTICS AG in Q1 2023. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75 | -19.4% | 1,663 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $93 | +564.3% | 1,663 | +427.9% | 0.00% | – |
| Q1 2023 | $14 | +7.7% | 315 | 0.0% | 0.00% | – |
| Q4 2022 | $13 | -99.9% | 315 | +9.0% | 0.00% | – |
| Q3 2022 | $19,000 | +5.6% | 289 | 0.0% | 0.00% | – |
| Q2 2022 | $18,000 | -85.0% | 289 | -84.9% | 0.00% | -100.0% |
| Q1 2022 | $120,000 | +14.3% | 1,913 | +38.3% | 0.00% | 0.0% |
| Q4 2021 | $105,000 | +12.9% | 1,383 | +65.6% | 0.00% | 0.0% |
| Q3 2021 | $93,000 | +287.5% | 835 | +460.4% | 0.00% | – |
| Q2 2021 | $24,000 | +33.3% | 149 | 0.0% | 0.00% | – |
| Q1 2021 | $18,000 | -10.0% | 149 | +12.0% | 0.00% | – |
| Q4 2020 | $20,000 | -37.5% | 133 | -65.7% | 0.00% | – |
| Q3 2020 | $32,000 | 0.0% | 388 | +15.5% | 0.00% | -100.0% |
| Q2 2020 | $32,000 | +128.6% | 336 | 0.0% | 0.00% | – |
| Q1 2020 | $14,000 | -26.3% | 336 | 0.0% | 0.00% | – |
| Q4 2019 | $19,000 | +35.7% | 336 | -3.4% | 0.00% | – |
| Q3 2019 | $14,000 | -12.5% | 348 | +4.8% | 0.00% | – |
| Q2 2019 | $16,000 | +33.3% | 332 | 0.0% | 0.00% | – |
| Q1 2019 | $12,000 | +71.4% | 332 | +30.7% | 0.00% | – |
| Q4 2018 | $7,000 | -36.4% | 254 | 0.0% | 0.00% | – |
| Q3 2018 | $11,000 | -26.7% | 254 | 0.0% | 0.00% | – |
| Q2 2018 | $15,000 | +25.0% | 254 | 0.0% | 0.00% | – |
| Q1 2018 | $12,000 | – | 254 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 508,558 | $82,330,000 | 27.28% |
| Valiant Capital Management, L.P. | 307,700 | $49,814,000 | 3.74% |
| NEA Management Company, LLC | 1,590,002 | $257,405,000 | 3.35% |
| NIA IMPACT ADVISORS, LLC | 39,891 | $6,458,000 | 3.15% |
| Ikarian Capital, LLC | 200,000 | $32,379,000 | 2.62% |
| Soleus Capital Management, L.P. | 103,114 | $16,693,000 | 2.57% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 157,334 | $25,471,000 | 2.47% |
| Capital Impact Advisors, LLC | 45,440 | $7,356,000 | 2.37% |
| ARK Investment Management | 7,776,119 | $1,258,876,000 | 2.34% |
| Sassicaia Capital Advisers LLC | 13,513 | $2,188,000 | 2.28% |